Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial

Maintenance immunosuppression with belatacept following kidney transplantation results in improved long-term graft function as compared with calcineurin inhibitors. However, broad application of belatacept has been limited, in part related to logistical barriers surrounding a monthly (q1m) infusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Aileen C., Karadkhele, Geeta M., Shenvi, Neeta, Easley, Kirk A., Larsen, Christian P., Badell, I. Raul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977481/
https://www.ncbi.nlm.nih.gov/pubmed/36875938
http://dx.doi.org/10.1097/TXD.0000000000001449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977481/
https://www.ncbi.nlm.nih.gov/pubmed/36875938
http://dx.doi.org/10.1097/TXD.0000000000001449

Ejemplares similares